JP Patent

JP2008150364A — レボフロキサシン含有錠剤

Assigned to Daiichi Sankyo Co Ltd · Expires 2008-07-03 · 18y expired

What this patent protects

【課題】水中での崩壊性および懸濁性に優れるレボフロキサシン含有錠剤の提供。【解決手段】成分（Ａ）：レボフロキサシン及び成分（Ｂ）：ポリビニル系結合剤を含有する錠剤。【選択図】なし

USPTO Abstract

【課題】水中での崩壊性および懸濁性に優れるレボフロキサシン含有錠剤の提供。【解決手段】成分（Ａ）：レボフロキサシン及び成分（Ｂ）：ポリビニル系結合剤を含有する錠剤。【選択図】なし

Drugs covered by this patent

Kalydeco (IVACAFTOR) · Vertex Pharms Inc

Patent Metadata

Patent number: JP2008150364A
Jurisdiction: JP
Classification: —
Expires: 2008-07-03
Drug substance claim: No
Drug product claim: No
Assignee: Daiichi Sankyo Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.